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Global health issues vary in the amount of attention and resources they receive.
One reason is that the networks of individuals and organizations that address
these issues differ in their effectiveness. This article presents key findings from a
research project on the emergence and effectiveness of global health networks
addressing tobacco use, alcohol harm, maternal mortality, neonatal mortality,
tuberculosis and pneumonia. Although networks are only one of many factors
influencing priority, they do matter, particularly for shaping the way the
problem and solutions are understood, and convincing governments, interna-
tional organizations and other global actors to address the issue. Their national-
level effects vary by issue and are more difficult to ascertain. Networks are most
likely to produce effects when (1) their members construct a compelling framing
of the issue, one that includes a shared understanding of the problem, a
consensus on solutions and convincing reasons to act and (2) they build a
political coalition that includes individuals and organizations beyond their
traditional base in the health sector, a task that demands engagement in the
politics of the issue, not just its technical aspects. Maintaining a focused frame
and sustaining a broad coalition are often in tension: effective networks find
ways to balance the two challenges. The emergence and effectiveness of a
network are shaped both by its members’ decisions and by contextual factors,
including historical influences (e.g. prior failed attempts to address the
problem), features of the policy environment (e.g. global development goals)
and characteristics of the issue the network addresses (e.g. its mortality burden).
Their proliferation raises the issue of their legitimacy. Reasons to consider them
legitimate include their members’ expertise and the attention they bring to
neglected issues. Reasons to question their legitimacy include their largely elite
composition and the fragmentation they bring to global health governance.
Keywords Alcohol harm, global health policy, health policy analysis, maternal mortality,
neonatal mortality, networks, pneumonia, tobacco control, tuberculosis
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KEY MESSAGES
 Global health networks—webs of individuals and organizations linked by a shared concern for a health condition—now
exist for most high-burden health problems that low- and middle-income countries face. They play major agenda-setting
and policy development roles, particularly by influencing how problems and solutions are understood and by recruiting
new actors to address the issues that concern them.
 Global health networks are most likely to be effective when they construct compelling framings of the issue and establish
political coalitions that extend beyond the health sector.
 Network emergence and effectiveness are shaped both by network decisions and by contextual factors, including
historical influences, their policy environment and characteristics of the issues they address.
Introduction
Global health issues vary in the amount of policy attention and
resources they receive. One reason is that the networks of
individuals and organizations that address these issues differ in
their effectiveness. Over the past quarter century, such net-
works have emerged for most high-burden health conditions, a
transformation in the way global health is governed.
This concluding article to the journal supplement presents key
findings from the Global Health Advocacy and Policy Project, a
research initiative on the emergence and effectiveness of global
health networks. Using a comparative historical research
approach, we investigated six networks in three matched
pairs, addressing addictive substances—tobacco and alcohol;
groups vulnerable at birth—pregnant women and newborn
babies; and communicable diseases affecting the respiratory
system—tuberculosis and pneumonia. Despite both issues in
each pair being of the same type and the second having
comparable or higher burden, the first has attracted greater
global priority (Table 1). Although both smoking and alcohol
use lead to high levels of illness and death (157 and 139 million
disability adjusted life years lost in 2010 and 2012, respectively)
(Lim et al. 2012; World Health Organization 2014a), tobacco
control has had markedly greater policy traction, evidenced
most notably by the passage of a 2003 global tobacco control
treaty and no such equivalent for alcohol harm. Despite
representing only about one-tenth the number of deaths (0.29
million vs 2.8 million in 2013) (Inter-agency Group for Child
Mortality Estimation 2014; Kassebaum et al. 2014), maternal
survival has attracted considerably greater donor financing than
newborn survival (Darmstadt et al. 2014; Institute for Health
Metrics and Evaluation 2015). And although tuberculosis and
pneumonia have a comparable mortality burden (in 2013, 1.1
million tuberculosis deaths overall vs. 935 000 pneumonia
deaths among children under five alone) (World Health
Organization 2014b; Liu et al. 2015), tuberculosis treatment
has been scaled-up to a far greater extent. As of the late 2000s,
directly observed treatment short course (DOTS)—the primary
intervention for TB—was available in 180 countries (World
Health Organization 2013a) and had averted an estimated 22
million deaths (World Health Organization 2013a); the scale-up
of pneumonia interventions lags far behind.
Drawing on a framework consisting of three categories of
factors (Table 2)—network and actor features, policy environ-
ment and issue characteristics (Shiffman et al. 2016)—we
conducted case studies of networks addressing each of the six
issues. Our aims were to explain (1) how networks emerge and
evolve; (2) what role networks play, if any, in generating policy
attention and (3) what factors shape the ability of networks to
do so. In the sections that follow, we draw on the framework
to present findings on each of these questions, with attention
to how network decisions and contextual factors—including
historical influences, policy environment and issue
characteristics—shaped network emergence and effectiveness.
We also consider network legitimacy—the question of by what
authority they exert power. In the discussion, we evaluate the
usefulness and limitations of the framework, identify deeper
themes that emerge from the studies and point to directions for
future research.
Network emergence
The studies indicate that global networks on each of the six
issues have existed for at least 15 years (Table 3). No single
factor stood behind the emergence of any of the six: rather, in
each case network appearance was the product of a confluence of
forces—the configurations slightly different for each (Table 4).
These included new information on the scope of the problem
(framework factor 8: severity); the condition’s appearance in new
forms or geographic regions (framework factor 8: severity);
dissatisfaction with existing efforts to address the condition and
with the way the condition was publicly understood (framework
factor 9: tractability; framework factor 4: framing strategies);
new evidence on how to address the problem (framework factor
9: tractability); new global agreements creating expectations that
states and other actors move to address the issue (framework
factor 7: norms); mobilization to counter industries marketing
products the use of which causes disease (framework factor 5:
allies and opponents) and concern that a particular population
group was being harmed (framework factor 10: affected groups).
In each case, the convergence of several of these factors led to a
decision by one or more concerned individuals to bring together
actors previously working in isolation with the intent of building
ties among them and spurring collective action (framework
factor 1: leadership).
For example, in the case of maternal survival, in 1985 for the
first time the World Health Organization (WHO) produced
evidence on the global scope of the problem—half a million
annual deaths. Around the same time, maternal health profes-
sionals were growing increasingly uneasy that maternal and
child health programs in low-income settings focused largely on
children (Shiffman and Smith 2007; Smith and Rodriguez
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2016). This state of affairs prompted Allan Rosenfield and
Deborah Maine to write an influential 1985 article published in
the prominent medical journal The Lancet titled, ‘Maternal
mortality—a neglected tragedy. Where is the M in MCH?’
(Rosenfield and Maine 1985). The article helped to spark a
global safe motherhood initiative, launched in 1987 at a
conference in Nairobi, Kenya, with the aim of reducing the
number of maternal deaths in childbirth by half by the year
2000 (Shiffman and Smith 2007). An Inter-Agency Group,
composed of the World Bank, a handful of United Nations
agencies and several international non-governmental organiza-
tions, guided the initiative initially, and its members formed the
original core of the network. For newborn survival, the stimulus
was the realization among researchers working on child
mortality that the newborn period constituted a growing
share of deaths to children under 5 years of age and that in
contrast to post-neonatal child mortality, little was being done
in low-income countries to address the neonatal period
(Shiffman 2016). Researchers organized a conference in 1999
at Johns Hopkins University in response. There, participants
heard evidence from the Indian physician Abhay Bang that
low-technology community and home-based interventions had
reduced newborn deaths in a locality in Maharashtra state,
generating hope among them that the problem could be
addressed across low-income settings. In 2000, concerned
individuals and organizations created the Healthy Newborn
Partnership to coordinate global efforts.
We observe similar patterns for the other four networks. In
1967, a network of tobacco control scientists and activists
coalesced around the first World Conference on Tobacco or
Health (Mamudu et al. 2011), 3 years after an influential US
Surgeon General’s report unequivocally stating the harm caused
by smoking. In the 1990s, tobacco control proponents from
around the world augmented their networked activities around
the negotiations of a global treaty on tobacco control–an idea
that had been created and promoted by leading network
members. During the treaty negotiations, the network brought
together dozens of NGOs working on the issue, leading to the
creation of a formal network organization in 1999–the
Framework Convention Alliance (FCA). (Gneiting 2016). For
alcohol harm, the trigger was dissatisfaction among alcohol
researchers surrounding the post-Prohibition abandonment of
public health strategies to address the issue and the consequent
dominance of individual behavioural and medical approaches
(Schmitz 2016). In 1986, they organized the Kettil Bruun
Society to re-introduce a public health approach.
The alarm caused by the re-appearance of tuberculosis in
Europe and North America in the late 1980s, growing concern
among African leaders about the disease, the convergence
surrounding DOTS as a treatment strategy and WHO leadership
formed the backdrop for the formation in 2001 of the Stop TB
Partnership, an alliance of organizations working on the issue
(Quissell and Walt 2016). The spark for pneumonia network
formation was the realization among researchers and national
Table 1 Issue type, burden and global priority for six issues investigated




Level of global priorityc
Tobacco use Addictive substance 157 6.0 Strong: legally binding treaty enacted in 2003
that has compelled nation-states to carry
out tobacco control measures.
Alcohol harm Addictive substance 139 3.3d Weak: non-binding global strategy not adopted
until 2010 and to date has had minimal
impact on national priority.
Maternal mortality
and morbidity
Group vulnerable at birth 16 0.3 Strong: 2010 UN-organized plan with heavy
maternal health component; $3.0 billion in
donor funding in 2014.
Neonatal mortality
and morbidity
Group vulnerable at birth 202 2.8 Moderate: while growing, as of 2010 only $613
million in donor non-research disburse-
ments across time for the issue.
Tuberculosis Communicable disease
affecting respiratory system
49 1.1e Strong: in 2014, $1.4 billion in donor funding




69f 0.9 (among children
under five only)
Moderate: in 2013, pneumococcal vaccine
policies in 192 countries but other inter-
ventions lagging.
Note: DALY, disability adjusted life years.
aWith exception of alcohol figure, which is for 2012, all figures are for 2010. Sources: tobacco (Lim et al. 2012); alcohol (World Health Organization 2014a) and
maternal, neonatal, tuberculosis and pneumonia (Murray et al. 2012).
bSources for mortality data: tobacco (World Health Organization 2013b); alcohol (World Health Organization 2014a); maternal mortality (Kassebaum et al.
2014); neonatal mortality (Inter-agency Group for Child Mortality Estimation 2014); tuberculosis (World Health Organization 2014b); childhood pneumonia
(Liu et al. 2015).
cSources for priority data: maternal (Institute for Health Metrics and Evaluation 2015); neonatal (Darmstadt et al. 2014); tuberculosis (Institute for Health
Metrics and Evaluation 2015; World Health Organization 2013a); pneumonia (World Health Organization and UNICEF 2015).
dFor 2012.
eDoes not include estimated 360 000 TB deaths among HIV-positive people, which are classified as HIV deaths according to ICD-10 (World Health Organization
2014b).
fCombined total for pneumococcal, H. influenza type B and respiratory syncytial virus pneumonias.
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Table 2 List of framework factors on the emergence and effectiveness of global health networks
Category Category explanation Factor Factor explanation
Network and
actor features
Factors internal to the network involving
strategy and structure, and attributes
of the actors that constitute the net-
work or are involved in creating it
Leadership A network is more likely to emerge and be effective if capable,
well-connected and widely respected champions are avail-
able to lead the cause.
Governance Networks are more likely to be effective if they have appro-
priate governing structures capable of facilitating collective
action and resolving disputes.
Composition Networks that link diverse actors are more likely to generate




Networks are more likely to be effective when their members
have discovered ways of positioning the issue that resonate
with external actors, especially political elites.
Policy
environment
Factors external to the network that
shape both its nature and the effects
the network hopes to produce
Allies and
opponents
Groups with aligned interests will facilitate network expansion
and power. Opponents will challenge network legitimacy
and issue promotion, but their existence may inspire
mobilization.
Funding Donor funding may facilitate network emergence and effect-
iveness and a dearth may hinder prospects for sustainability,
but over-reliance on these resources may hamper network
legitimacy.
Norms Widely held expectations that global actors address a particular
condition facilitate network emergence. Networks that




Features of the problem the network
seeks to address
Severity Network emergence and effectiveness are more likely sur-
rounding problems that are perceived to have high mortality,
morbidity or socioeconomic costs.
Tractability Networks are more likely to form and be effective surrounding
problems for which solutions exist or are perceived to exist,




Network emergence and effectiveness are more likely on issues
that affect groups that are readily identifiable, that societies
view sympathetically and that are able to advocate for
themselves.
Table 3 The six networks studied—initial and most recent forms
Network studied Initial formation Current structure/organization
Tobacco use 1967: Network of scientists and activists coalesces around
first World Conference on Tobacco or Health.
1999: FCA forms as formal coalition of NGOs around global
tobacco control treaty; over past decade, expansion and
decentralization of network including new funding
partner networks, regional networks, and national-level
coalitions
Alcohol harm 1986: Alcohol harm researchers form Kettil Bruun Society,
re-introducing idea that substance is a public health
threat.
2000: Global Alcohol Policy Alliance forms, bringing
together more than 200 alcohol policy and public health
advocates from about 30 countries, in effort to broaden
the network beyond Europe and North America.
Maternal mortality 1987: Network forms following a conference in Kenya that
launches global safe motherhood initiative. Initiative
initially guided by Inter-Agency Group, comprised of
representatives from international organizations and
NGOs.
2005: Partnership for Maternal, Newborn and Child Health
forms (PMNCH), although it is only one among multiple
institutions that presently connect maternal health
actors. As of 2015, PMNCH links more than 680
organizations.
Neonatal mortality 1999: Network emerges following conference at Johns
Hopkins on perinatal mortality in low-income settings.
Proponents establish Healthy Newborn Partnership in
2000 to link concerned individuals and organizations.
2014: Global action plan on newborn survival appears,
organized by small, informal group of researchers and
program officers most of whom, since 2000, have
constituted network’s core.
Tuberculosis Early 1990s: Coalition emerges linking researchers, donors,
advocates and political leaders who understand TB to be
a global public health emergency.
2001: Coalition is formalized in the form of the Stop TB
Partnership, which as of 2012 encompasses approxi-
mately 1600 individuals and organizations.
Childhood pneumonia 1984: A short-lived network emerges linking officers and
researchers in global and national programs dedicated to
community care of the disease.
2003: Influential actors begin to rebuild network around a
broader identity encompassing a larger spectrum of
interventions, including vaccines.
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program managers in low-income countries that the disease
was killing many children and that community-based solutions
could help address the problem (Berlan 2016). In the 1980s,
they conveyed this information to the WHO, which in 1984
organized an acute respiratory infection program, providing a
platform to link individuals concerned about the disease.
Network effects
The studies demonstrate that although their efforts were only
one of multiple factors shaping priority, these networks did
matter, particularly for global agenda-setting and policy devel-
opment. They did so by (1) bringing global attention to the
neglect and severity of the problems that concerned them
(framework factor 8: severity), (2) advancing solutions (frame-
work factor 9: tractability) and (3) negotiating and mobilizing
to secure global agreements, convince new actors to address the
issue and—for tobacco control and alcohol harm—counter
opponents (framework factor 3: composition; framework factor
5: allies and opponents). Their national effects—on policy
adoption, intervention scale-up and population health—are
more difficult to ascertain and varied by issue. In most
instances, they had more pronounced global than national
effects because the majority of network members worked in
organizations operating globally—including research institu-
tions, international organizations, donor agencies and interna-
tional NGOs—and focused their efforts primarily, if not
exclusively, at that level. Also, barriers to national change
were considerable—often more formidable than global
obstacles—and included competing national development prio-
rities, political instability and weak health infrastructures.
Network effects on global agenda setting and policy
development
The six networks were among the first actors to publicize the
neglect and severity of the conditions that concerned them, and
they continue to monitor and raise awareness of the scope of
these problems (framework factor 8: severity). The tobacco
control network that emerged in 1967 helped to bring global
attention to the adverse effects of the product. The FCA that
formed in 1999 has published several monitoring reports high-
lighting discrepancies between FCTC members’ commitments and
actions (Gneiting 2016). Researchers in the alcohol network
systematically monitor alcohol-related harm, contribute to the
WHO’s Global Status Report on Alcohol and Health and generate data
for Global Burden of Disease reports (Schmitz 2016). Maternal
survival proponents, through the safe motherhood initiative
launched in 1987, raised global awareness of the half million
annual deaths due to maternal death in childbirth (Smith and
Rodriguez 2016). From 2000 on newborn survival proponents,
through the Healthy Newborn Partnership and other mechan-
isms, brought global attention to the fact that neonatal mortality
constituted >40% of deaths among children under 5 years of age
and that this was the portion of child mortality declining at the
slowest pace (Shiffman 2016). The Countdown to 2015, an
alliance that includes maternal and newborn survival network
members, produces regular monitoring reports tracking coverage
of health interventions for maternal, newborn and child survival
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org/reports-and-articles). A network of individuals alarmed about
the tuberculosis epidemic helped to secure the 2000 Amsterdam
Declaration and 2001 Washington Commitment, major global
political commitments to address the disease (Quissell and Walt
2016). They support the WHO on global surveillance of the
disease, including since 2010 its multi-drug-resistant variant.
Under the auspices of the WHO’s Acute Respiratory Infection
Program, individuals concerned about pneumonia were among
the first to raise awareness about its high mortality among
children (Berlan 2016). Via a network re-constituted in the 2000s,
they support an annual World Pneumonia Day and have used
data produced by the Child Health Epidemiology Reference Group
to publicize pneumonia as the world’s leading killer of children.
Network members also generated, synthesized and dissemi-
nated research that provided evidence on the tractability of the
problems they were addressing (framework factor 9: tractability).
Network members contributed evidence on the effectiveness of
tax increases and limits on marketing for an influential 1999
World Bank study calling for greater tobacco control in low-
income countries (World Bank 1999). The WHO’s Global Status
Report on Alcohol and Health prominently mentions research by
network members on the efficacy of tax increases and marketing
restrictions (World Health Organization 2014a). A 2009 Lancet
series, focused on alcohol as ‘one of the most pressing public
health problems in the world’, also profiles this research and
network member policy recommendations (Lancet 2009, p.
2171). From the 1990s on researchers core to the maternal
survival network produced hundreds of studies on maternal
mortality and conceived of and contributed the bulk of the
material for three influential Lancet series on maternal survival
(in 2006, 2007 and 2013), laying out the need for quality
intrapartum care (Shiffman and Smith 2007; Smith and
Rodriguez 2016). Between 2000 and 2015, newborn survival
network members—most of whom were researchers—expanded
the evidence base on how to address the issue and in doing so
altered the perception that newborn survival was an intractable
problem in low-income settings (Shiffman 2016). As with
maternal survival, they conceived of and organized influential
Lancet series (in 2005 and 2014) demonstrating the tractability of
the problem. Tuberculosis network members conduct much of
the research on TB diagnostics, drugs and vaccines, producing
knowledge that informs WHO policies (Quissell and Walt 2016).
In the 1980s, individuals concerned with pneumonia developed
guidance for the WHO on diagnosing and addressing pneumonia
in communities and hospitals (Berlan 2016). A reconstituted
network in the 2000s produced reviews of prior research,
including an influential 2008 issue of the Bulletin of the World
Health Organization and an article based on a collective effort to
identify pneumonia research gaps (Rudan et al. 2011).
In addition, networks mobilized and negotiated to recruit new
actors, build coalitions, acquire resources and secure global
agreements on the issues that concerned them (framework factor
3: composition; framework factor 5: allies and opponents).
Network members actively sought support from within the
WHO and recruited tobacco control advocates from around the
world, leading to an expansion in formal network membership of
the FCA from 60 organizations in 1999 to approximately 500
presently. The network also expanded its reach through new
funding sources, such as the significant support by Bloomberg
Philanthropies and the Bill and Melinda Gates Foundation.
Although the Global Alcohol Policy Alliance has not experienced
FCA’s growth nor attracted significant funding, it was able
during the 2000s to create a number of regional networks
(Schmitz 2016). In the first 5 years of the safe motherhood
initiative, maternal survival network members engaged repre-
sentatives of > 80 countries through national and regional
conferences. In the late 2000s, although not all of these
represented new pledges, they helped to draw an estimated
$40 billion in commitments from 127 stakeholders for the Global
Strategy for Women’s and Children’s Health. The TB network
early on garnered the support of USAID in financing TB efforts.
As of 2012 Stop TB Partnership individual and organizational
membership had reached approximately 1600, and the number
of advocacy NGOs and local organizations signing onto the
Global Plan continues to grow (Quissell and Walt 2016).
Newborn survival network members convinced UNICEF to take
up the issue and used their board positions in the Partnership for
Maternal, Newborn and Child Health to ensure that it did not
neglect the newborn (Shiffman 2016). Pneumonia network
members produced and disseminated research that may have
influenced the creation of an Advanced Market Commitment for
a pneumococcal vaccine and decisions by the Gates Foundation
and GAVI to address the disease (Berlan 2016). Moreover, each
network was centrally involved in the conceptualization and
crafting of an influential global plan, strategy or framework that
has spurred action on these problems: the 2001 Global Plan to
Stop TB, the 2003 Framework Convention on Tobacco Control,
the 2009 and 2013 Global Action Plans for Prevention and
Control of Pneumonia (and Diarrhoea in the latter plan), the
2010 Global Strategy to Reduce the Harmful Use of Alcohol, the
2010 Global Strategy on Women’s and Children’s Health and the
2014 Every Newborn Action Plan. Most recently, several of the
networks influenced the content of Sustainable Development
Goal (SDG) number three on health (Box 1). United Nations
member states officially adopted the SDGs in September 2015.
Network effects on national policy
While all six networks played large global agenda-setting and
policy development roles, their national policy effects are more
difficult to ascertain and vary by issue. Tobacco, tuberculosis
and maternal survival networks had more pronounced national
policy effects than those for newborn survival, pneumonia and
alcohol. By pushing for and monitoring country compliance
with the FCTC, tobacco network members helped to facilitate a
doubling in the number of people protected by comprehensive
smoke-free laws—to 787 million—between 2008 and 2010 and
have influenced policy on other issues such as pictorial health
warnings and advertising bans (Eriksen et al. 2012; Gneiting
2016). The Global Stop TB Partnership supported the cross-
national diffusion of DOTS (World Health Organization 2013a;
Quissell and Walt 2016). Research by TB network members has
informed country strategic plans, particularly in the 22 highest
burden countries (World Health Organization 2014b). A ma-
ternal survival network facilitated country policy adoption by
organizing regional and national safe motherhood conferences
between 1987 and 1992 and helping UN agencies and other
partners to develop roadmaps for maternal and newborn health
in 33 African countries in the mid-2000s (de Bernis and
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Box 1 Network influence on the SDGs
The 17 SDGs, unanimously adopted by United Nations member states in September 2015, are the latest expression of global
development priorities. Goal three concerns health (‘Ensure healthy lives and promote well-being for all at all ages.’ See
http://www.globalgoals.org/global-goals/good-health, accessed 4 January 2016).
We conducted most of our research prior to major deliberations on the SDGs. For this concluding paper, we sought to bring
our findings up-to-date by examining what influence the networks we studied had on the SDG health targets. We reached
out via e-mail and telephone to 14 key informants to gather information on this question.
Five of the six issues we studied are mentioned explicitly (italics added) in SDG 3 (there are additional elements to SDG 3
that are not listed below):
 By 2030, reduce the global maternal mortality ratio to < 70 per 100 000 live births
 By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal
mortality to at least as low as 12 per 1000 live births and under-5 mortality to at least as low as 25 per 1,000 live births
 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-
borne diseases and other communicable diseases
 Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol
 Strengthen the implementation of the WHO Framework Convention on Tobacco Control in all countries, as appropriate
Pneumonia is not mentioned explicitly but is included implicitly since it is a leading cause of under-5 mortality.
Information from key informants provides evidence that the networks, to varying degrees, influenced the selection of these
issues for inclusion and the targets selected:
 The fact that maternal mortality was in the MDGs made it highly likely that it would be included in the SDGs, given the
impetus to complete this unfinished agenda. Maternal survival proponents shaped the content of the goal by engaging UN
and donor agencies and coming to a consensus on the target to be included. In 2014, a meeting was organized by the WHO,
the Maternal Health Task Force, United Nations Population Fund, USAID and the Maternal and Child Health Integrated
Program concerning Ending Preventable Maternal Mortality (United States Agency for International Development 2014).
The meeting included many core maternal survival network members. There representatives from 30 countries agreed on a
2030 global target MMR of < 70 per 100 000 live births. It is that target that is included in the SDGs.
 With respect to child survival, global actors involved in formulating the SDGs initially focused their attention on sustaining an
under-5 mortality target, as a continuation of the MDGs. Initiatives and advocacy by newborn survival proponents influenced
the decision to add a neonatal mortality target. Particularly influential was their organization of a global conference on
newborn survival in Johannesburg, South Africa in 2013; their creation of an Every Newborn Action Plan in 2014 which
included a neonatal mortality target; their links with a UN-led global Every Woman Every Child movement and advocacy
within their own organizations, many of which participated in SDG development. The target included in the SDGs—‘to reduce
neonatal mortality to at least as low as 12 per 1,000 live births’—came from the Every Newborn Action Plan.
 Organizations within the TB network influenced the SDG negotiation process through several different mechanisms. First,
the WHO had a coordinating role in defining SDG 3 and its targets and indicators. This was done in continuous
consultation with its Global TB Programme (GTB). GTB stayed closely engaged with the proceedings in New York to
ensure TB’s inclusion, and the final language of the target to ‘end the epidemics of AIDS, tuberculosis, and malaria’
directly reflects the 2014 End TB Strategy elaborated by GTB in consultation with its advisory bodies, governments,
national programs, partners, and civil society, and agreed upon by all WHO Member States at the World Health Assembly
in May 2014. The Stop TB Partnership and many of the activist organizations also advocated on behalf of this target.
 The alcohol and tobacco networks have been producing evidence on harm, linking this to development questions and
proposing solutions. Their success in doing so likely increased the probability of mention of tobacco control and alcohol
harm in the SDGs. However, for both alcohol and tobacco, the language in the SDGs does not include specific reduction
targets (in contrast to road traffic accidents which have a specific target of 50% reduction in injuries and deaths by 2020).
A general target establishes the goal, ‘to reduce by one third premature mortality from non-communicable diseases.’ This
gives states extensive leeway with regard to the risk factors they choose to address. Tobacco is mentioned as a separate
target under Goal 3, but it requires states only to, ‘strengthen the implementation of the WHO Framework Convention on
Tobacco Control, as appropriate.’ Alcohol is not included as a separate target but mentioned alongside other substance
abuse issues. States are asked in very general terms to ‘strengthen prevention and treatment’. While the FCA engaged in
systematic lobbying at the international and domestic levels to push tobacco control onto the SDG agenda, members of
the alcohol control network had no sustained involvement in SDG negotiations. However, they did participate in the 2011
UN Meeting on NCDs which defined the global response by 2030.
 Pneumonia does not appear anywhere in the SDGs. This may be due to a combination of a lack of network member focus
on seeking to influence the goals and limited influence beyond the child survival community. Follow-up correspondence
with four networks members who play leadership and coordination roles reveal that none of them personally participated in
the SDG process. They reported knowing of some colleagues who did so, but in each case those participating focused on a
broader issue, like child survival, access to essential medicines or immunizations, rather than securing a pneumonia
reference. The lack of a reference to pneumonia in the SDGs, especially compared to issues with significantly lower mortality
burdens, is viewed by some of the respondents as indication of a lack of broader influence by the network.
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Wolman 2009; Smith and Rodriguez 2016). Between 1990 and
2010, there was a moderate decline in the global maternal
mortality ratio—3.1% per annum (World Health Organization,
United Nations Children’s Fund, United Nations Population
Fund and The World Bank 2012)—although it is difficult to
assess the contribution of network activity to this change, as
many other factors likely were influential, including improve-
ments in the status of women and programming on other
issues such as family planning.
A newborn survival network pushed for national adoption of
policies and programs to reduce neonatal mortality, but only a
handful of countries have devoted significant public resources
to the issue (Darmstadt et al. 2014; Shiffman 2016). And while
neonatal mortality declined at a rate of 2.1% per annum
between 2000, the year of network formation, and 2010, there
is no strong evidence that newborn survival programs were a
major contributor (Lawn et al. 2012, 2014). While there has
been a sustained decline in child pneumonia (from 3.6 million
in 1991 to 0.9 million in 2013) (Garenne et al. 1992; Liu et al.
2015), network efforts were strong only from the late 2000s on,
so the limited network influence on policy to date could not be
primarily responsible (Berlan 2016). And although 66 WHO
member states had written national alcohol policies as of 2012
(World Health Organization 2014a), few countries have strong
programs to address alcohol harm (Schmitz 2016). It may take
more time for the alcohol harm network to capitalize on the
2010 Global Strategy but progress is lagging when compared to
the first 5 years after the FCTC entered into force.
Other factors shaping outcomes
Networks were hardly the sole source of change in policy
outcomes, even for global agenda setting where their effects
were most pronounced. Changes in issue characteristics and the
policy environment, and the efforts of individual, rather than
networked, actors also shaped global attention to these issues.
For instance, the AIDS-related re-emergence of tuberculosis in
Western Europe and North America in the late 1980s—an issue
characteristic—was the initial spark for a resurgence of global
attention to the disease. The significant rise in harm caused by
smoking and drinking in low- and middle-income countries
created considerable demand for action that contributed to the
formation and influence of global health networks addressing
these problems. The inclusion of maternal mortality as a
Millennium Development Goal (MDG)—a feature of the policy
environment only tangentially influenced by network
members—was a major reason for the growth in attention to
this issue through the 2000s (Smith and Rodriguez 2016). The
1999 study on home-based care for the newborn by Abhay
Bang and colleagues—research conducted with minimal inter-
action with global institutions—was the original catalyst that
shifted perceptions on the tractability of the problem (Shiffman
2016). Nevertheless, evidence from the case studies strongly
indicates that networks were an influential contributor, par-
ticularly to raising global attention to these issues.
Sources of network effectiveness
Many factors shaped the flourishing of networks and conse-
quently their capacity to generate attention and resources. Two,
however, were influential in all cases (Table 5). First, the more
effective networks constructed a compelling framing of the issue
(framework factor 4: framing strategies), one that encompassed
a shared understanding of the problem, a consensus on solutions
and convincing reasons to act [what social movement scholars
term diagnostic, prognostic and motivational framing (Snow and
Benford 1988)]. These reasons pertained to the threat the
problem posed, an ethical imperative or both. Such a framing
facilitated network coalescence and inspired others to work on
the issue. Second, those networks helped build political coalitions
that included individuals and organizations beyond their trad-
itional bases in the health sector, a task that necessitated their
engagement in the politics of the issues, not just technical
aspects (framework factor 3: composition and framework factor
5: allies and opponents). Sustaining a cohesive frame and
building a broad coalition were often in tension: the former
demanded focus, the latter wide appeal. Effective networks
found ways to balance the two challenges.
Table 5 Network coalitions and issue framing
Network Nature of coalition Framing of issue
Tobacco use Relatively broad: researchers and advocates from high
and low-income countries
Cohesive: a public health threat, with industry as the vector
of disease
Alcohol harm Narrow: largely researchers from high-income countries Contested: public health framing competes with individual
behavioural and medical framings
Maternal mortality Broad: initially insular, evolves into political coalition
linking researchers, advocates and politicians from
high and low-income countries
Cohesive: an ethical imperative—a matter of women’s
rights and equity—that requires urgent action due to
slow progress
Neonatal mortality Narrow: tight core of health-oriented professionals;
expansion beyond health sector has been slow
Cohesive but inadequate: essential for achieving MDG 4.
But other strong rationales that political leaders might
find compelling and urgent have yet to emerge
Tuberculosis Broad: researchers, advocates and political leaders from
high and low-income countries, linked via Stop TB
Partnership
Relatively cohesive: a social threat, with DOTS as core
strategy to address the disease (although some dis-
agreement on DOTS’ efficacy)
Childhood pneumonia Narrow and unstable: emerges, dissolves then
reappears—a function of shifting ties with broader
child survival initiatives and internal differences over
interventions
Contested: forceful positioning as ‘leading killer of chil-
dren’, but historically disagreement over whether it
should be a stand-alone issue or integrated into child
survival
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The three comparisons reveal the influence of these two
factors in shaping network effectiveness. After two decades of
disagreements on interventions, in the mid-2000s prominent
maternal survival proponents coalesced around a strategy
emphasizing emergency obstetric care, skilled attendance at
birth and access to comprehensive reproductive health services,
including family planning (Shiffman and Smith 2007; Smith
and Rodriguez 2016). Also, slow progress on the maternal
survival MDG and growing expectations that governments
prioritize women’s rights and health put pressure on political
leaders to act (Smith and Rodriguez 2016). These same
pressures led to the emergence in the mid-2000s of a broad
political coalition on maternal survival, one the network helped
build, that included the UN Secretary-General and heads of
state from low and high-income countries (Smith and
Rodriguez 2016). For 15 years following the 1987 emergence
of a maternal survival initiative, the network’s composition had
been limited largely to technical actors from Northern agencies
(Shiffman and Smith 2007; Smith and Rodriguez 2016).
Newborn survival has not yet benefited from similar positive
shifts in framing and network composition (Shiffman 2016).
While network members largely agreed on the interventions
Box 2 Future research questions on global health networks
1. Emergence:
a. While the studies indicate that multiple configurations of factors stand behind network emergence, would investigating
a larger sample of networks reveal that one (or more) configuration is particularly common?
b. Why did global health network proliferation begin in the 1970s and 1980s? What historical forces shaped their
appearance at this particular juncture?
c. Are we likely to see the same rate of global health network proliferation over the next 40 years as we have seen in the
past 40 years? Is the global health network space becoming crowded, a factor that might make it difficult for future
networks to gain traction?
2. Global agenda-setting:
a. Are networks more effective if they proceed in stages: first—in order to generate momentum—building a tight coalition
of actors concentrated in the health sector who are sympathetic to the cause and embrace a shared framing of the issue,
and then loosening the framing to appeal to a broader set of actors, expanding the coalition beyond the health sector?
b. Under what circumstances are confrontational tactics (such as those employed by tobacco control and HIV/AIDS
initiatives) advantageous for generating sustained attention to an issue?
c. Is it primarily the production of objective evidence on tractability that enables networks to influence the agenda status
of an issue or rather their ability to shape the perception that a problem can be surmounted?
d. Even in the absence of global health networks, would individuals and organizations have produced the technical and
medical knowledge now available? Might the distinctiveness of global health networks lie more in their linking of this
evidence with normative claims, adding a moral element to the process? (Kapstein and Busby 2010)
3. National effects:
a. Once they have had global agenda-setting influence, why are some networks more effective in producing national
effects than others?
b. How do the quality of linkages with national networks influence global health network effectiveness?
c. How do the appropriateness of their framing strategies for national level contexts influence their effectiveness?
d. Are there life-cycle effects: do the limited national effects of some networks have as much to do with their relative
youth as with any deficiency in strategies?
e. Which country-specific factors explain differential receptiveness to global health networks?
4. Framework generalizability:
a. To what extent are the framework categories of network and actor features, policy environment and issue characteristics
useful for explaining the emergence and effectiveness of global health networks in categories not studied in this project,
including those addressing health systems issues (e.g. health workforce), environmental risk factors (e.g. industrial
pollution) and interventions (e.g. vaccinations)?
b. What influential factors does the framework miss? For emergence? For effectiveness?
5. Legitimacy:
a. What dimensions ought to be considered in assessing the legitimacy of global health networks (e.g. transparency,
inclusiveness, representation, expertise, effectiveness)? What ethical frameworks should be used to assess their
legitimacy?
b. Why are some networks perceived to be more legitimate than others?
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needed to reduce neonatal mortality and advanced arguments
for attention to the issue (especially its rising share of child
mortality and its centrality to achieving the child survival
MDG), they never discovered a framing that provided a sense of
urgency and that national political leaders found sufficiently
compelling to justify the provision of extensive public resources.
Moreover, while expanding to some degree, the composition of
the network’s core (a small group of committed health
professionals and the health-oriented agencies they work for)
has changed little since its emergence in the 2000s. And while
there are some signs of movement, including attempts to
mobilize parent groups on preterm birth and success in building
alliances to secure a neonatal mortality target in the SDGs (Box
1), a sustained, broad political coalition has yet to appear.
Tobacco control and alcohol harm networks also differed on
framing and composition. The tobacco control network, while
tight-knit and with strict entry requirements (e.g. no contact
with industry), evolved into a strong political coalition linking
researchers and activists who shared an understanding of
tobacco use as a public health threat, the industry as the vector
of disease and governments as having an obligation to enact
anti-tobacco legislation (Gneiting 2016; Gneiting and Schmitz
2016). The coalition expanded beyond its original core to
include regional and national networks and extensive civil
society involvement. It was influential in securing adoption of a
global framework on tobacco control, in marginalizing the to-
bacco industry and in promoting the national adoption of anti-
tobacco measures. In contrast, the alcohol harm network has
consisted largely only of researchers, linked by an understand-
ing of alcohol harm as a threat to public health (Schmitz 2016;
Gneiting and Schmitz 2016). They have faced other groups that
view the issue not as a public health but as an individual
behavioural or medical problem (Schmitz 2016). Narrow
network composition as a result of a lack of consensus across
like-minded groups on the nature of the problem has hampered
advocacy and is one reason for inadequate resources and
national policies to address alcohol harm.
Framing strategies and political composition also help to
explain the differential effectiveness of tuberculosis and pneu-
monia networks (Berlan 2016; Quissell and Walt 2016). A
perception of tuberculosis as a social threat and the existence of
a medical specialty led to the formation of institutions to address
the disease as early as the mid-1800s, a process that continued
through the 20th century. These institutions in turn shaped the
formation in the 1990s of a strong coalition linking researchers,
donors, advocates and political leaders who understood tubercu-
losis to be a global public health emergency and DOTS a
promising strategy to address the disease. In 2001, this coalition
was formalized in the form of the Stop TB Partnership. The
network’s strength enabled it to take advantage of opportunities
for generating attention and resources—including the MDGs, the
creation of the Global Fund to Fight AIDS, Tuberculosis and
Malaria and HIV-TB co-infection—and to influence cross-na-
tional policy adoption and the scaling-up of interventions. In
contrast, a pneumonia network, consisting predominantly of
researchers and program officers in the health sector, has been
slow to coalesce and only emerged as a consequential actor in
global health in the past several years. Several factors stood
behind this slow coalescence (Berlan 2016): pneumonia was
never understood to be a social threat; it did not inspire the
formation of a medical specialty dedicated to address it;
disagreements over intervention strategy, while less stark now,
fragmented the community of individuals concerned with the
disease; and efforts to address the disease have at certain points
been subsumed under broader child survival initiatives. Problems
with coalescence and framing, among other factors, have meant
that while global efforts to address pneumonia have proceeded,
the network has only been a secondary force in shaping attention
to the disease, in promoting national policy adoption and in
facilitating mortality decline (Berlan 2016).
The paired comparisons reveal tensions between constructing
unifying frames and building broad coalitions, and networks
have struggled to balance the two challenges. The maternal
survival network linked its social justice demands with child
survival concerns to expand the set of actors demanding action
on both maternal and child mortality, although tensions
between the two sets of actors persist (Shiffman and Smith
2007; Shiffman 2010; Smith and Rodriguez 2016). The WHO TB
Department, sustaining a focus on DOTS as a solution and a
central role in the Partnership’s governance structure, has faced
challenges from NGOs and other organizations that question
the value of such an intervention strategy and concentration of
power in the face of emergent multi-drug-resistant strains and
HIV-TB co-infection (Quissell and Walt 2016). The network’s
future effectiveness will undoubtedly depend on its ability to
modify its public positioning of the issue and governance
mechanisms in ways that keep these challengers on board,
without losing frame coherence. The tobacco network’s public
health framing of the issue has brought it cohesion and
influence in national policy matters such as smoke-free envir-
onments; to make progress on other issues such as taxation it
may need to broaden the public health frame to recruit non-
health sector allies, potentially unsettling the network’s unity
(Gneiting 2016). The pneumonia network has faced an ongoing
struggle to sustain an identity for the issue amidst a broader
child survival initiative (Berlan 2016). Progress on newborn
survival and alcohol harm may depend on an expansion beyond
the health sector of the coalitions backing the issues, which in
turn may require these networks to construct framings of the
issue that extend beyond the public health positionings that
they have emphasized to date (Schmitz 2016; Shiffman 2016).
The paired comparisons and case studies also reveal the
influence of historical and political context, and of issue
characteristics, on network framing and coalition-building deci-
sions. The perceptions of tuberculosis as a social threat and of
DOTS as an effective intervention strategy (framework factor 9:
tractability) preceded the formation of the Stop TB Partnership.
The Partnership leveraged these perceptions to its advantage in
framing the issue and recruiting allies (Quissell and Walt 2016).
Evidence on tobacco’s lethality (framework factor 8: severity)
and the existence of an industry that denied the fact and sought
to expand markets (framework factor 5: allies and opponents)
catalysed tobacco control network expansion and the framing of
the industry as the vector of disease (Gneiting 2016). Women’s
rights norms advanced during the UN Decade for Women and
development norms advanced by the MDGs (framework factor 7:
norms) influenced maternal network expansion and the social
justice framing of the issue (Smith and Rodriguez 2016).
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In addition, the paired comparisons and case studies demon-
strate the influence of factors beyond framing and coali-
tion-building strategies on network effectiveness. For instance,
the FCA’s and Stop TB Partnership’s formal, centralized govern-
ance structures (framework factor 2: governance) were more
effective in facilitating collective action than the decentralized
institutions established by alcohol harm and pneumonia pro-
ponents (although prior to formalization, the FCA as an ad hoc
coalition influenced negotiations surrounding the FCTC, indicat-
ing that informal arrangements are not incompatible with
agenda-setting power) (Berlan 2016; Gneiting 2016; Schmitz
2016; Quissell and Walt 2016). Tobacco control and tuberculosis
networks also benefited from entrepreneurial champions (frame-
work factor 1: leadership)—prominent individuals who were
instrumental in bringing together actors and generating global
agreements to address these issues—a feature that alcohol harm
and pneumonia networks lacked (Berlan 2016; Gneiting 2016;
Schmitz 2016; Quissell and Walt 2016). Another crucial factor
was financing (framework factor 6: funding). For instance,
extensive donor funding for maternal survival has been both a
dependent and independent variable—a product of maternal
survival network advocacy but also a facilitator of the entry of
new organizations into this field and of network expansion
(Smith and Rodriguez 2016). The dearth of funding for alcohol
harm to date has hindered the growth of this network.
Network legitimacy
The proliferation of networks raises a question about their
legitimacy: by what authority do they exert power? Some
network members may wonder why this issue need be raised,
presuming that their public-spirited aspirations and positive
effects on health provide sufficient justification for their
initiatives. Scholars writing on the legitimacy of civil society
organizations (Atack 1999; Avant et al. 2010), however, argue
that there are additional dimensions to legitimacy, including
the extent to which these actors have significant representation
from marginalized populations. Democratic theorists, too, offer
strong reasons for not taking legitimacy for granted, contending
that the right to exert power is contingent not just on
performance—what they term output legitimacy—but also fair
process, inclusive deliberation and transparency—or input
legitimacy (Dahl 1971; Daniels 2000; Schmidt 2013).
On output and input legitimacy grounds, there are several
reasons to consider these networks legitimate actors in global
health governance. First, they raised attention to and resources
for high burden health conditions that national governments
might otherwise have neglected or failed to address adequately.
Second, they brought considerable expertise to bear on these
problems; in their absence, we would know much less about
their scope and how to address them. Third, they added new
voices—including some from civil society—to policy processes
that might otherwise have been dominated by national
governments and international organizations.
However, there are also reasons to raise questions. First, elites
from Northern institutions have controlled many of these
networks; in the majority, Southern institutions have had
limited representation and even more so for citizens of
Southern countries—the often marginalized individuals most
affected by the problems that these networks seek to address.
Second, these networks in some instances contributed to the
fragmentation of global and national health governance, ham-
pering the creation of cohesive global health strategies and
strong national health systems. For instance, critics complained
that separate newborn survival efforts splintered child survival
initiatives (Shiffman 2010); that distinct national tuberculosis
control programs contributed to fragmented care for patients
with HIV and TB co-infection (Friedland et al. 2007); and that a
specific focus on maternal mortality detracted from a broader
women’s health and rights agenda (Yamin and Boulanger
2014). Also, with the possible exception of the tobacco control
network, these networks have not fundamentally challenged
the structure of power in global health governance: rather, they
have sought to carve out their own spaces within that structure.
The larger issue is the place of these networks in the governance
of global and national health: to what extent do the deficiencies
of international organizations and national governments in
addressing pressing health problems justify their existence; to
what extent do they exert power without legitimate authority?
There may be some truth in both perspectives.
Discussion
The studies demonstrate that while other factors were influential,
the networks played central roles in raising global attention for
tobacco control, alcohol harm, maternal survival, newborn
survival, tuberculosis and pneumonia. This finding is not an
obvious one. The networks might have failed in their efforts. Or
attention might have emerged entirely due to other factors, such
as the individual rather than networked activity of involved
actors, the influence of powerful nation-states or donors, growth
in the severity of the problems, and new solutions.
As we suggest in the introductory paper, one way to consider
network effects is to envision the counter-factual: in the absence
of these networks, would attention to these conditions have
appeared anyway and to the same degree? There is no way to
know with certainty, as we cannot re-run history and compare a
world lacking these global health networks with the world we
live in. However, we can consider what level of attention might
have emerged if maternal survival proponents had not launched
a global safe motherhood initiative in 1987; if tobacco control
proponents had not pressed for the creation of a global treaty or
national level compliance with the provisions of the FCTC; if
newborn survival network members had conducted no research
on interventions appropriate for low-income settings; if the Stop
TB Partnership had never coalesced; if alcohol harm researchers
had left the issue to providers focused on individual treatment; if
pneumonia network members had not publicized data demon-
strating that the disease was the world’s leading killer of
children. Possibly other forces may have converged to produce
the same agenda-setting effects. However, it seems reasonable to
presume that this is unlikely and that the networks accelerated
policy change, if not always to the extent they hoped for.
The conceptual framework proved to be useful in identifying
the factors that gave these networks global agenda-setting
power and that shaped their emergence (Table 6), although
additional studies should assess whether the framework
includes all major variables and whether the three framework
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categories are the most useful way to arrange inquiry. This
factor identification function is in line with the purpose of
frameworks: to organize research by providing the most general
list of variables that need to be considered for theory generation
(Ostrom 2007; Sabatier 2007). Future research on global health
networks should aim toward such theory specification.
In several ways, the case studies provide us direction toward
this end. First, they reveal the role of history in shaping network
outcomes, suggesting the need for a dynamic theory that clarifies
how early decisions influence network emergence and effective-
ness. Prior efforts to address these conditions influenced how the
networks crystallized, the forms they took and their initial
framing of the issues; network crystallization and the initial
framings in turn shaped network evolution; and the networks’
evolutionary patterns influenced their effectiveness. Second, the
case studies point to the capacity of networks to shape political
priority even in the face of historical barriers, adverse policy
environments and difficult issue characteristics—suggesting the
need for a theory that incorporates not just structural influences
but also agency. Third, the case studies identify the core factors
that gave these networks the capacity to prompt political change,
influences that potentially might ground a theory of network
agency. Among these were strong evidence on severity—no
network emerged or was effective without this; convincing
frames encompassing clear problem definitions, coherent solu-
tions and compelling reasons to act and coalition-building
strategies that extended beyond the health sector.
These three points suggest that we might usefully characterize
networks as engaged in strategic social construction that is path
dependent—an idea that may prove valuable for theory devel-
opment on global health networks. The idea of path dependence
(Collier and Collier 1991; Mahoney 2000; Pierson 2000) pertains
to the strong influence of initial decisions on subsequent
developments, a result of increasing costs to change over time.
The idea of strategic social construction (Finnemore and Sikkink
1998; Khagram et al. 2002) refers to the capacity of actors, acting
instrumentally on principled concerns, to shape social reality.
Strategic social construction that is path dependent implies that
Table 6 Factors behind network emergence and effectivenessa
Category Factor Role of factor in network emergence Role of factor in network effectiveness
Network and
actor features
Leadership Individual champions helped to spark network
formation by bringing together actors
previously working in isolation (all six
cases)
Strong individual leaders provided vision for net-
works, enabling them to flourish and to raise
attention for the conditions they addressed (to-
bacco control; tuberculosis)
Governance Formalized and centralized governance arrangements
facilitated network collective action, although in
some instances hampered their adaptability
(tuberculosis; tobacco control)
Composition Diverse membership—especially inclusion of political
leaders outside the health sector—enhanced net-




Deficiencies of existing issue frames influenced
decisions to organize a network and choices
on initial framing (alcohol harm; maternal
survival; tobacco control)
Cohesive frames—including clear problem definitions,
coherent solutions and compelling reasons to act—
unified networks and enhanced their effectiveness
(tobacco control; maternal survival; tuberculosis)
Policy environment Allies and
opponents
The existence of strong opponents inspired
network mobilization (tobacco control; al-
cohol harm)
Industry counter-strategies obstructed network efforts
(alcohol harm; tobacco control); Allied global
movements brought additional attention and re-
sources
(tuberculosis—support from the AIDS movement)
Funding Donor funding provided resources that facilitated
network expansion (tuberculosis; tobacco control;
maternal survival; newborn survival)
Norms Existing expectations that states and other
entities address the issue or related issues,
catalysed network formation (maternal sur-
vival; tuberculosis; tobacco control)
Global normative expectations, particularly those
advanced by the MDGs, catalysed network
expansion and action (maternal survival)
Issue characteristics Severity Evidence on the scope and neglect of a
condition spurred network formation (all six
cases)
Networks successfully developed and deployed evi-
dence on severity to generate resources and attract
allies (all six cases)
Tractability New policy solutions or evidence that a prob-
lem was potentially surmountable facilitated
network formation (tuberculosis; newborn
survival; pneumonia)
Networks successfully developed and deployed evi-
dence on solutions, resulting in augmented atten-
tion and resources (newborn survival; tuberculosis;
tobacco control)
Affected groups Evidence of neglect of a particular population
group spurred network formation (newborn
survival; maternal survival; pneumonia)
Evidence of neglect of a particular population group
facilitated network expansion (newborn survival;
maternal survival)
aCases where the factor worked in a decisively positive direction for the network or condition are in parentheses. An empty box does not imply that the factor
is irrelevant. Rather, it indicates that we did not find strong evidence that it played a major causal role in the six cases we selected for investigation.
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forces connected both to structure and agency influence global
health outcomes. It suggests that network effectiveness is
historically conditioned but not historically determined: strategic
networks can transcend historically imposed barriers and in-
attentive networks can squander historically provided opportu-
nities. Future research on networks oriented toward theory
development would do well to examine how historical precedent
and structural forces, on the one hand, interact with individual
and organizational agency, on the other, to produce global health
outcomes. Crucial questions (Box 2) include:
 Why did global health network proliferation begin in the
1970s and 1980s?
 Is there a particular configuration of factors that most
commonly stands behind network emergence?
 Are networks more effective if they proceed in stages, first
building a tight coalition of like-minded actors and then
loosening the framing of the issue to create a broader
alliance extending beyond the health sector?
 Why are some global networks better able to produce
national effects than others? How does the quality of
linkages with national networks shape this capacity?
 What ethical considerations should be used to assess the
legitimacy of global health networks?
As the empirical studies in this supplement demonstrate, global
health networks addressing specific conditions and issues have
emerged as major actors in the global health field, serving central
agenda-setting roles. They are not likely to lose relevance any
time soon, even as global health actors attempt to consolidate
efforts surrounding a few common goals such as universal health
coverage. These networks are products of their historical condi-
tions but once created they alter the global health landscape that
they join. We can expect that they will continue to do so, and
that more networks will appear on issues and conditions still to
be identified. For all these reasons, global health networks
deserve our ongoing research attention.
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